Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

What to know about spring break, graduations and other key dates at public schools and colleges in the Tuscaloosa area.

Tixagevimab-cilgavimab reduced risk for severe COVID-19 progression in patients with hematologic malignancies on anti-CD20 therapy during the early Omicron era.

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

Norovirus is commonly referred to as the stomach flu, stomach bug or as the “cruise ship virus” because it’s often the cause ...

As South Korea battled a spike in flu cases, misinformation swirled online that the country was suffering a resurgence of the Omicron XBB coronavirus variant, which was "five times stronger" and "more ...

The new five-type index, developed by federal researchers with the National Institutes of Health’s RECOVER COVID Initiative, ...

The following is a summary of “60-day mortality and the role of SARS-CoV-2 in hospital admissions of immunocompromised patients during later Omicron period: a population-based study in Sweden,” ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

Two MSU sororities hosted their 18th annual Biennial Beautillion where they awarded two students with scholarships.

A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...